Company profile
Xenetic Biosciences, Inc.
NASDAQ:XBIOBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03077698 | phase2 | terminated | 2017-06-14 | 2020-07-17 | Xenetic Biosciences, Inc. | An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer |
FDA applications (0)
No records yet.